United Therapeutics UTHR Earnings Call Transcripts

NASDAQ UTHR
$588.61 +6.15 (+1.06%)
At close: Nov 10, 2026 · 4:00 PM EST
14 earnings calls on file for United Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

United Therapeutics Q3 2026 Earnings Call

Nov 4, 2026 4,392 words · 19 min read
  • Harry SilversInvestor Relations
  • Martine RothblattChairperson and Chief Executive Officer
  • Michael BenkowitzPresident and Chief Operating Officer
  • James EdgemondChief Financial Officer and Treasurer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

United Therapeutics Earnings Call Transcripts

Calls14
LatestNov 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 14 United Therapeutics transcripts Register to get access to United Therapeutics’s earnings call transcripts.